Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Emma Arnesdotter, Vera Rogiers, Tamara Vanhaecke & Mathieu Vinken. (2021) An overview of current practices for regulatory risk assessment with lessons learnt from cosmetics in the European Union. Critical Reviews in Toxicology 51:5, pages 395-417.
Read now
Read now
Lisa Wiesner, Maarten Prause & Ester Lovsin Barle. (2018) Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE). Pharmaceutical Development and Technology 23:3, pages 261-264.
Read now
Read now
Ester Lovsin Barle, Jean-Claude Bizec, Milica Glogovac, Kamila Gromek & Gian Christian Winkler. (2018) Determination and application of the permitted daily exposure (PDE) for topical ocular drugs in multipurpose manufacturing facilities. Pharmaceutical Development and Technology 23:3, pages 225-230.
Read now
Read now
D. A. Dankovic, B. D. Naumann, A. Maier, M. L. Dourson & L. S. Levy. (2015) The Scientific Basis of Uncertainty Factors Used in Setting Occupational Exposure Limits. Journal of Occupational and Environmental Hygiene 12:sup1, pages S55-S68.
Read now
Read now
Randa N. Haddadin, Suhair A. Saleh, Manal A. Ayyash & Phillip J. Collier. (2013) Occupational exposure of pharmaceutical workers to drug actives and excipients and their effect on Staphylococcus spp. nasal carriage and antibiotic resistance. International Journal of Occupational and Environmental Health 19:3, pages 207-214.
Read now
Read now
A.M.J. Ragas. (2011) Trends and challenges in risk assessment of environmental contaminants. Journal of Integrative Environmental Sciences 8:3, pages 195-218.
Read now
Read now
Mark S. V. Maier. (2011) Setting occupational exposure limits for unstudied pharmaceutical intermediates using an in vitro parallelogram approach. Toxicology Mechanisms and Methods 21:2, pages 76-85.
Read now
Read now
DiannL. Blanset, Junfeng
(Jim) Zhang & MarkG. Robson. (2007) Probabilistic Estimates of Lifetime Daily Doses from Consumption of Drinking Water Containing Trace Levels of N,N-diethyl-meta-toluamide (DEET), Triclosan, or Acetaminophen and the Associated Risk to Human Health. Human and Ecological Risk Assessment: An International Journal 13:3, pages 615-631.
Read now
Read now
BruceD. Naumann, DavidG. Dolan & EdwardV. Sargent. (2004) Rationale for the Chemical-Specific Adjustment Factors Used to Derive an Occupational Exposure Limit for Timolol Maleate. Human and Ecological Risk Assessment: An International Journal 10:1, pages 99-111.
Read now
Read now
A. G. Renwick. (2000) The use of safety or uncertainty factors in the setting of acute reference doses. Food Additives & Contaminants 17:7, pages 627-635.
Read now
Read now
DuckH. Suh & MohamedS. Abdel‐Rahman. (1997) Assessing human health risks of chemicals and drugs: An overview. Human and Ecological Risk Assessment: An International Journal 3:4, pages 599-615.
Read now
Read now
AbdelrazakM. Kadry, DuckH. Suh & MohamedS. Abdel‐Rahman. (1997) Kinetic and dynamic data of analgesics and NSAIDs drugs reduce 10X uncertainty factors. Human and Ecological Risk Assessment: An International Journal 3:4, pages 567-578.
Read now
Read now
BruceD. Naumann, PatriciaA. Weideman, Rakesh Dixit, ScottJ. Grossman, C. Frank Shen & EdwardV. Sargent. (1997) Use of toxicokinetic and toxicodynamic data to reduce uncertainties when setting occupational exposure limits for pharmaceuticals. Human and Ecological Risk Assessment: An International Journal 3:4, pages 555-565.
Read now
Read now
Articles from other publishers (49)
Jiayang Kong, Yun Lu, Yunru Ren, Menghao Chen, Gang Liu & Liangliang Shi. (2024) The risk factors and threshold level of subchronic inhalation exposure of reclaimed water. Journal of Environmental Sciences 137, pages 639-650.
Crossref
Crossref
Aishwarya Ray, Patrick Forrestal, Chikere Nkwonta, Niharika Rahman, Pilar Byrne, Martin Danaher, Karl Richards, Sean Hogan & Enda Cummins. (2023) Modelling potential human exposure to the urease inhibitor NBPT through the environment-food pathway. Environment International 179, pages 108149.
Crossref
Crossref
Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet & Dean Calhoun. (2023) The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits. Journal of Applied Toxicology.
Crossref
Crossref
Gunnar Johanson, Tshepo Paulsen Moto & Linda Schenk. (2022) A scoping review of evaluations of and recommendations for default uncertainty factors in human health risk assessment. Journal of Applied Toxicology 43:1, pages 186-194.
Crossref
Crossref
Lisa Wiesner, Selene Araya & Ester Lovsin Barle. (2022) Identifying nonhazardous substances in pharmaceutical manufacturing and setting default health‐based exposure limits (HBELs). Journal of Applied Toxicology 42:9, pages 1443-1457.
Crossref
Crossref
Varun Ahuja & Mohan Krishnappa. (2021) Approaches for setting occupational exposure limits in the pharmaceutical industry. Journal of Applied Toxicology 42:1, pages 154-167.
Crossref
Crossref
Zhen Wang, Yolina Yu Lin Wang, W. Casan Scott, E. Spencer Williams, Michael Ciarlo, Paul DeLeo & Bryan W. Brooks. (2021) Comparative influences of dermal and inhalational routes of exposure on hazards of cleaning product ingredients among mammalian model organisms. Environment International 157, pages 106777.
Crossref
Crossref
Mohammad Charehsaz, Gulcin Tugcu & Ahmet Aydin. (2020) Filling data gap for nicotinic acid, nicotinate esters and nicotinamide for the determination of permitted daily exposure by a category approach. Toxicological Research 37:3, pages 337-344.
Crossref
Crossref
Dennis J. Paustenbach & William D. Cyrs. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
1
51
.
Etienne F. Dumont, Amanda J. Oliver, Chris Ioannou, Julia Billiard, Jeremy Dennison, Frans van den Berg, Shuying Yang, Vijayalakshmi Chandrasekaran, Graeme C. Young, Anirban Lahiry, David C. Starbuck, Andrew W. Harrell, Alex Georgiou, Nathalie Hopchet, Andy Gillies & Stephen J. Baker. (2020) A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study. Antimicrobial Agents and Chemotherapy 64:5.
Crossref
Crossref
Andrew Maier, Debra Cherry & Elizabeth Friedman. 2020. Information Resources in Toxicology. Information Resources in Toxicology
443
452
.
Zhen Wang, Dan Dinh, W. Casan Scott, E. Spencer Williams, Michael Ciarlo, Paul DeLeo & Bryan W. Brooks. (2019) Critical review and probabilistic health hazard assessment of cleaning product ingredients in all-purpose cleaners, dish care products, and laundry care products. Environment International 125, pages 399-417.
Crossref
Crossref
Zhen Wang, Bryan W. Brooks, Eddy Y. Zeng & Jing You. (2019) Comparative mammalian hazards of neonicotinoid insecticides among exposure durations. Environment International 125, pages 9-24.
Crossref
Crossref
Camille Jandard, Helena Hemming, Maarten Prause, Claudia Sehner, Markus Schwind, Marc Abromovitz & Ester Lovsin Barle. (2018) Applicability of surface sampling and calculation of surface limits for pharmaceutical drug substances for occupational health purposes. Regulatory Toxicology and Pharmacology 95, pages 434-441.
Crossref
Crossref
Zhen Wang, W. Casan Scott, E. Spencer Williams, Michael Ciarlo, Paul C. DeLeo & Bryan W. Brooks. (2018) Identification of novel uncertainty factors and thresholds of toxicological concern for health hazard and risk assessment: Application to cleaning product ingredients. Environment International 113, pages 357-376.
Crossref
Crossref
E.V. Sargent, B.D. Naumann & C.S. Schwartz. 2018. Comprehensive Toxicology. Comprehensive Toxicology
44
63
.
Anthony J. Streeter & Ellen C. Faria. (2017) Analysis of the variability of the pharmacokinetics of multiple drugs in young adult and elderly subjects and its implications for acceptable daily exposures and cleaning validation limits. International Journal of Hygiene and Environmental Health 220:4, pages 659-672.
Crossref
Crossref
E.V. Sargent, B.D. Naumann & C.S. Schwartz. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Robert Sussman & John Farris. 2016. Antibody‐Drug Conjugates. Antibody‐Drug Conjugates
151
175
.
Eileen P. Hayes, Robert A. Jolly, Ellen C. Faria, Ester Lovsin Barle, Joel P. Bercu, Lance R. Molnar, Bruce D. Naumann, Michael J. Olson, Alison M. Pecquet, Reena Sandhu, Bryan K. Shipp, Robert G. Sussman & Patricia A. Weideman. (2016) A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing – Operational considerations. Regulatory Toxicology and Pharmacology 79, pages S39-S47.
Crossref
Crossref
John F. Reichard, M. Andrew Maier, Bruce D. Naumann, Alison M. Pecquet, Thomas Pfister, Reena Sandhu, Edward V. Sargent, Anthony J. Streeter & Patricia A. Weideman. (2016) Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals. Regulatory Toxicology and Pharmacology 79, pages S67-S78.
Crossref
Crossref
Robert G. Sussman, Anthony R. Schatz, Tracy A. Kimmel, Allan Ader, Bruce D. Naumann & Patricia A. Weideman. (2016) Identifying and assessing highly hazardous drugs within quality risk management programs. Regulatory Toxicology and Pharmacology 79, pages S11-S18.
Crossref
Crossref
Robert G. Sussman, Bruce D. Naumann, Thomas Pfister, Claudia Sehner, Christopher Seaman & Patricia A. Weideman. (2016) A harmonization effort for acceptable daily exposure derivation – Considerations for application of adjustment factors. Regulatory Toxicology and Pharmacology 79, pages S57-S66.
Crossref
Crossref
Ester Lovsin Barle, Gian Christian Winkler, Peter Ulrich, Christopher Perino, Martin Kuster, Alessandro Probst, Silke Thielen & Rudolf Bechter. (2014) Cancer risk of immunosuppressants in manufacturing. Regulatory Toxicology and Pharmacology 70:1, pages 122-124.
Crossref
Crossref
Edward V. Sargent, Ellen Faria, Thomas Pfister & Robert G. Sussman. (2013) Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products. Regulatory Toxicology and Pharmacology 65:2, pages 242-250.
Crossref
Crossref
Bruce D. Naumann, Patricia A. Weideman, Ramesh Sarangapani, Shu-Cheih Hu, Rakesh Dixit & Edward V. Sargent. (2009) Investigations of the Use of Bioavailability Data to Adjust Occupational Exposure Limits for Active Pharmaceutical Ingredients. Toxicological Sciences 112:1, pages 196-210.
Crossref
Crossref
Robert G. Sussman, Edward V. Sargent & Todd L. Davidson. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Thomas Fuller. 2009. Handbook of Modern Hospital Safety, Second Edition. Handbook of Modern Hospital Safety, Second Edition
1
25
.
Andrew Maier. 2009. Information Resources in Toxicology. Information Resources in Toxicology
335
343
.
Paul S. Price, Russell E. Keenan & Jeffrey C. Swartout. (2008) Characterizing interspecies uncertainty using data from studies of anti-neoplastic agents in animals and humans. Toxicology and Applied Pharmacology 233:1, pages 64-70.
Crossref
Crossref
J English. 2006. Toxicological Testing Handbook. Toxicological Testing Handbook
79
107
.
AG Renwick. (2006) Toxicology of Micronutrients: Adverse Effects and Uncertainty. The Journal of Nutrition 136:2, pages 493S-501S.
Crossref
Crossref
Bradley W. Schwab, Eileen P. Hayes, Janice M. Fiori, Frank J. Mastrocco, Nicholas M. Roden, David Cragin, Roger D. Meyerhoff, Vincent J. D’Aco & Paul D. Anderson. (2005) Human pharmaceuticals in US surface waters: A human health risk assessment. Regulatory Toxicology and Pharmacology 42:3, pages 296-312.
Crossref
Crossref
J.L.C.M. Dorne, K. Walton & A.G. Renwick. (2005) Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. Food and Chemical Toxicology 43:2, pages 203-216.
Crossref
Crossref
J.L.C.M. Dorne. (2004) Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation. Fundamental and Clinical Pharmacology 18:6, pages 609-620.
Crossref
Crossref
B Schilter, C Andersson, R Anton, A Constable, J Kleiner, J O'Brien, A.G Renwick, O Korver, F Smit & R Walker. (2003) Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food and Chemical Toxicology 41:12, pages 1625-1649.
Crossref
Crossref
J.L.C.M Dorne, K Walton & A.G Renwick. (2003) Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. Food and Chemical Toxicology 41:2, pages 225-245.
Crossref
Crossref
Lynne T. Haber & Andrew Maier. (2002) Scientific Criteria Used for the Development of Occupational Exposure Limits for Metals and Other Mining-Related Chemicals. Regulatory Toxicology and Pharmacology 36:3, pages 262-279.
Crossref
Crossref
J.L.C.M Dorne, K Walton, W Slob & A.G Renwick. (2002) Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?. Food and Chemical Toxicology 40:11, pages 1633-1656.
Crossref
Crossref
Andrew G Renwick. (2002) Pesticide residue analysis and its relationship to hazard characterisation (ADI/ARfD) and intake estimations (NEDI/NESTI). Pest Management Science 58:10, pages 1073-1082.
Crossref
Crossref
W. H. Bailey. (2002) DEALING WITH UNCERTAINTY IN FORMULATING OCCUPATIONAL AND PUBLIC EXPOSURE LIMITS. Health Physics 83:3, pages 402-408.
Crossref
Crossref
L. Edler, K. Poirier, M. Dourson, J. Kleiner, B. Mileson, H. Nordmann, A. Renwick, W. Slob, K. Walton & G. Würtzen. (2002) Mathematical modelling and quantitative methods. Food and Chemical Toxicology 40:2-3, pages 283-326.
Crossref
Crossref
J.L.C.M Dorne, K Walton & A.G Renwick. (2001) Uncertainty factors for chemical risk assessment. Food and Chemical Toxicology 39:7, pages 681-696.
Crossref
Crossref
Lynne T. Haber, Joan S. Dollarhide, Andrew Maier & Michael L. Dourson. 2003. Patty's Toxicology. Patty's Toxicology.
A.G Renwick, J.L Dorne & K Walton. (2000) An Analysis of the Need for an Additional Uncertainty Factor for Infants and Children. Regulatory Toxicology and Pharmacology 31:3, pages 286-296.
Crossref
Crossref
Robert J Scheuplein. (2000) Pesticides and Infant Risk: Is There a Need for an Additional Safety Margin?. Regulatory Toxicology and Pharmacology 31:3, pages 267-279.
Crossref
Crossref
Dale Hattis, J Prerna Banati, Rob Goble & David E. Burmaster. (1999) Human Interindividual Variability in Parameters Related to Health Risks. Risk Analysis 19:4, pages 711-726.
Crossref
Crossref
M.N. Pieters, H.J. Kramer & W. Slob. (1998) Evaluation of the Uncertainty Factor for Subchronic-to-Chronic Extrapolation: Statistical Analysis of Toxicity Data. Regulatory Toxicology and Pharmacology 27:2, pages 108-111.
Crossref
Crossref
A.G. Renwick & N.R. Lazarus. (1998) Human Variability and Noncancer Risk Assessment— An Analysis of the Default Uncertainty Factor. Regulatory Toxicology and Pharmacology 27:1, pages 3-20.
Crossref
Crossref